How to Buy Biodexa Pharmaceuticals Stock
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally.
Biodexa Pharmaceuticals stock last closed at $1.00, down 9.91% from the previous day, and has decreased 94.37% in one year. It has underperformed other stocks in the Biotechnology industry by 0.75 percentage points. Biodexa Pharmaceuticals stock is currently +49.25% from its 52-week low of $0.67, and -95.19% from its 52-week high of $20.80.
There are currently 1.7B shares of BDRX outstanding. The market cap of BDRX is $5.10M. In the past 24 hours, 248,326 BDRX shares were traded.
How to Buy Biodexa Pharmaceuticals Stock
Wondering how to invest in Biodexa Pharmaceuticals stock? Here's how.
- Figure out where to buy Biodexa Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Biodexa Pharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Pick your payment method and add your information.
- Research Biodexa Pharmaceuticals stock: The Biodexa Pharmaceuticals ticker symbol is BDRX. Is Biodexa Pharmaceuticals stock a good investment? Should you buy shares of BDRX? How do BDRX's underlying business fundamentals look? Do top analysts think Biodexa Pharmaceuticals is a good buy? Why has BDRX's stock price moved recently? (Hint: Our stock research website can help you evaluate if BDRX is a good stock to buy).
- Place your BDRX buy order: Decide if you will purchase BDRX shares at the current market price or use a limit order to buy BDRX stock at a specific price.
- Get key alerts regarding your investment in BDRX: Create a watchlist to get the latest news on your new investment in Biodexa Pharmaceuticals stock.
Step 1: Figure out where to buy Biodexa Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy BDRX shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you need to fill out some personal information so you can buy BDRX today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open your new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have opened your account on the best stock app for beginners, your next step is to transfer the money for your investment:
Watch this video walkthrough to see the process of depositing money into your investment account.
Step 4: Research Biodexa Pharmaceuticals stock
Once you have figured out the best place to buy Biodexa Pharmaceuticals stock, it's important to research their stock before you invest, so you can understand the risk and opportunity.
Biodexa Pharmaceuticals Numbers
Fundamentals of BDRX
WallStreetZen was designed to help everyday investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on BDRX's stock page.
Is BDRX stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge BDRX's intrinsic value.
Using relative valuations ratios:
- BDRX may be undervalued based on its P/B ratio of 0.88x, relative to Biotechnology industry P/B ratio of 6.06x
You can access more valuation analysis on BDRX's stock here.
BDRX Financials at a glance
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the BDRX balance sheet.
- BDRX has $7.37M in cash and short term investments. This is sufficient to cover its annual cash burn of $9.50M.
- There are more short-term assets than short-term liabilities on the BDRX balance sheet.
Negative Financial Indicators:
- BDRX has a relatively high debt to equity ratio of 1.25.
- Total BDRX debt is higher than 5 years ago, relative to shareholder equity.
- BDRX profit margin has gone down from -1,095.3% to -1,858% in the past year.
- BDRX has cash burn of 9497530. It does not have sufficient cash and short-term investments to cover this.
Is it a good time to buy Biodexa Pharmaceuticals stock, according to Wall Street analysts?
Out of 1 Wall Street analysts who track BDRX, the consensus analyst rating on Biodexa Pharmaceuticals is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Biodexa Pharmaceuticals stock forecast page.
BDRX Momentum
How are BDRX Revenues/Earnings doing?
Last year, BDRX revenue was $470.37k. Over the past five year, BDRX's revenue has increased by -27.81% per year. This was slower than the Biotechnology industry average of 30.02%.
Find out more about BDRX's earnings and revenue performance here.
Who is buying/selling BDRX?
In the past 12 months, insiders at BDRX have not bought or sold any shares.
Dig into more about who owns BDRX stock here.
Can I get consistent income from BDRX stock?
No, Biodexa Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about BDRX?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your BDRX buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, place a limit order.
Press the Open Trade button and eToro will place your order.
If you want more help investing in stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your investment in BDRX
Now that you own some shares in BDRX, you'll want to keep up with your investment.
Make a watchlist to get alerted to the latest events about your BDRX stock.
BDRX Feed
How to Buy Stock in Biodexa Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Biodexa Pharmaceuticals:
- Figure out where to buy Biodexa Pharmaceuticals stock
- Open your brokerage account
- Put funds into your investment account
- Research Biodexa Pharmaceuticals stock
- Place your BDRX buy order
- Get key alerts regarding your investment in BDRX
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Biodexa Pharmaceuticals, create your watchlist below.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.